INVALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Subject is scheduled for a procedure that requires │ Subject is scheduled for a procedure that requires │     100 │
│ general or neuraxial anesthesia                    │ general or neuraxial anesthesia                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects must have normal or clinically acceptable │ Subjects must have normal or clinically acceptable │     100 │
│ physical exam                                      │ physical exam                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Females must have a urine or serum pregnancy test  │ Females must have a urine or serum pregnancy test  │     100 │
│ (Human Chorionic Gonadotropin) that is negative at │ (Human Chorionic Gonadotropin) that is negative at │         │
│ Screening and Day 1                                │ Screening and Day 1                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject's parent or legal guardian gives informed  │ Subject's parent or legal guardian gives informed  │     100 │
│ consent and subject gives assent                   │ consent and subject gives assent                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject's age is between ≥12 and 16 years,         │ Subject's age is between =12 and 16 years,         │      98 │
│ inclusive                                          │ inclusive                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects with controlled diabetes prior to entry   │ Subjects with controlled diabetes prior to entry   │      99 │
│ must have a mean systolic/diastolic office blood   │ must have a mean systolic/diastolic office blood   │         │
│ pressure ≤128/78 mmHg (sitting, after 5 minutes of │ pressure =128/78 mmHg (sitting, after 5 minutes of │         │
│ rest)                                              │ rest)                                              │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 12 Years                  │ Subjects must have normal or clinically acceptable │      41 │
│                                                    │ physical exam                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 16 Years                  │ Subject's age is between =12 and 16 years,         │      42 │
│                                                    │ inclusive                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject has any serious medical condition which,   │ Females must have a urine or serum pregnancy test  │      43 │
│ in the opinion of the investigator, is likely to   │ (Human Chorionic Gonadotropin) that is negative at │         │
│ interfere with study procedures                    │ Screening and Day 1                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects who have a history of any clinically      │ Subjects must have normal or clinically acceptable │      44 │
│ significant local or systemic infectious disease   │ physical exam                                      │         │
│ within four weeks prior to initial treatment       │                                                    │         │
│ administration                                     │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject has a contraindication to vasoconstrictor  │ Subjects with controlled diabetes prior to entry   │      47 │
│ therapy for control of blood pressure              │ must have a mean systolic/diastolic office blood   │         │
│                                                    │ pressure =128/78 mmHg (sitting, after 5 minutes of │         │
│                                                    │ rest)                                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject has participated in other clinical trials  │ Subject's parent or legal guardian gives informed  │      47 │
│ for investigational drugs and/or devices within 30 │ consent and subject gives assent                   │         │
│ days prior to enrollment                           │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects taking antihypertensive medication        │ Subject's age is between =12 and 16 years,         │      48 │
│                                                    │ inclusive                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subject is moribund (death is likely to occur in   │ Subject is scheduled for a procedure that requires │      48 │
│ less than 48 hours)                                │ general or neuraxial anesthesia                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Females who are pregnant, nursing or unwilling to  │ Females must have a urine or serum pregnancy test  │      49 │
│ use/practice adequate contraception                │ (Human Chorionic Gonadotropin) that is negative at │         │
│                                                    │ Screening and Day 1                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Subjects who are positive for hepatitis B surface  │ Subject is scheduled for a procedure that requires │      52 │
│ antigen or hepatitis C antibody                    │ general or neuraxial anesthesia                    │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only CHIA has the following criteria:
╒════════════════════════════════════════════╤═════════════════╤═════════╕
│ Personal Criteria                          │ CHIA Criteria   │   Score │
╞════════════════════════════════════════════╪═════════════════╪═════════╡
│ Subject's age is between ≥12 and 16 years, │ NA              │       0 │
│ inclusive                                  │                 │         │
╘════════════════════════════════════════════╧═════════════════╧═════════╛

Levenshtein Ratio of Entire trial at once: 57
Average Levenshtein Ratio of individual lines: 62.23529411764706
OverAll Ratio: 59.61764705882353
